Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical Investigation
J Clin Invest. 1989 October; 84(4): 1070–1075.
PMCID: PMC329762

Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies.


Primary IgA nephropathy (IgAN) is characterized by mesangial deposits of IgA1, increased serum IgA1 levels, and circulating immune complexes containing predominantly IgA1. It has previously been found that patients with IgAN have a higher than normal IgA response to vaccination, but the IgA subclasses have not been studied. To investigate whether the IgA hyperresponsiveness is limited to the subclass IgA1, which is involved in the pathogenesis of IgAN, we compared the immune responses of 18 patients with 22 healthy controls after intramuscular vaccination with inactivated influenza virus. Antibody titers were significantly higher (P less than 0.0001) for the IgA1 subclass in patients versus controls, but not for the other isotypes. A substantial portion of the IgA and IgA1 antiinfluenza immune response comprised polymers in both patients and controls. There was no preferential response of polymers in patients. Patients produced significantly more monomeric IgA1 antibodies than controls. These results show that patients with IgAN have a hyperresponsiveness limited to the subclass IgA1 and mainly expressed by an excess of monomers.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987 Sep;64(245):709–727. [PubMed]
  • Conley ME, Cooper MD, Michael AF. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest. 1980 Dec;66(6):1432–1436. [PMC free article] [PubMed]
  • Tomino Y, Endoh M, Nomoto Y, Sakai H. Immunoglobulin A1 and IgA nephropathy. N Engl J Med. 1981 Nov 5;305(19):1159–1160. [PubMed]
  • Hall RP, Stachura I, Cason J, Whiteside TL, Lawley TJ. IgA-containing circulating immune complexes in patients with igA nephropathy. Am J Med. 1983 Jan;74(1):56–63. [PubMed]
  • Lomax-Smith JD, Zabrowarny LA, Howarth GS, Seymour AE, Woodroffe AJ. The immunochemical characterization of mesangial IgA deposits. Am J Pathol. 1983 Dec;113(3):359–364. [PubMed]
  • Katz A, Newkirk MM, Klein MH. Circulating and mesangial IgA in IgA nephropathy. Contrib Nephrol. 1984;40:74–79. [PubMed]
  • Valentijn RM, Radl J, Haaijman JJ, Vermeer BJ, Weening JJ, Kauffmann RH, Daha MR, van Es LA. Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int. 1984 Nov;26(5):760–766. [PubMed]
  • Sato M, Kojima H, Takayama K, Koshikawa S. Glomerular deposition of food antigens in IgA nephropathy. Clin Exp Immunol. 1988 Aug;73(2):295–299. [PubMed]
  • van der Peet J, Arisz L, Brentjens JR, Marrink J, Hoedemaeker PJ. The clinical course of IgA nephropathy in adults. Clin Nephrol. 1977 Aug;8(2):335–340. [PubMed]
  • Clarkson AR, Seymour AE, Thompson AJ, Haynes WD, Chan YL, Jackson B. IgA nephropathy: a syndrome of uniform morphology, diverse clinical features and uncertain prognosis. Clin Nephrol. 1977 Nov;8(5):459–471. [PubMed]
  • Lesavre P, Digeon M, Bach JF. Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy. Clin Exp Immunol. 1982 Apr;48(1):61–69. [PubMed]
  • Delacroix DL, Elkom KB, Geubel AP, Hodgson HF, Dive C, Vaerman JP. Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A. J Clin Invest. 1983 Feb;71(2):358–367. [PMC free article] [PubMed]
  • Jones C, Mermelstein N, Kincaid-Smith P, Powell H, Roberton D. Quantitation of human serum polymeric IgA, IgA1 and IgA2 immunoglobulin by enzyme immunoassay. Clin Exp Immunol. 1988 May;72(2):344–349. [PubMed]
  • van den Wall Bake AW, Daha MR, van der Ark A, Hiemstra PS, Radl J, van Es LA. Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy. Clin Exp Immunol. 1988 Oct;74(1):115–120. [PubMed]
  • Tomino Y, Miura M, Suga T, Endoh M, Nomoto Y, Sakai H. Detection of IgA1-dominant immune complexes in peripheral blood polymorphonuclear leukocytes by double immunofluorescence in patients with IgA nephropathy. Nephron. 1984;37(2):137–139. [PubMed]
  • Czerkinsky C, Koopman WJ, Jackson S, Collins JE, Crago SS, Schrohenloher RE, Julian BA, Galla JH, Mestecky J. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest. 1986 Jun;77(6):1931–1938. [PMC free article] [PubMed]
  • van den Wall Bake AW, Daha MR, Radl J, Haaijman JJ, Van der Ark A, Valentijn RM, Van Es LA. The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy. Clin Exp Immunol. 1988 May;72(2):321–325. [PubMed]
  • Nagy J, Brandtzaeg P. Tonsillar distribution of IgA and IgG immunocytes and production of IgA subclasses and J chain in tonsillitis vary with the presence or absence of IgA nephropathy. Scand J Immunol. 1988 Apr;27(4):393–399. [PubMed]
  • Bene MC, Faure G, Duheille J. IgA nephropathy: characterization of the polymeric nature of mesangial deposits by in vitro binding of free secretory component. Clin Exp Immunol. 1982 Mar;47(3):527–534. [PubMed]
  • Tomino Y, Sakai H, Miura M, Endoh M, Nomoto Y. Detection of polymeric IgA in glomeruli from patients with IgA nephropathy. Clin Exp Immunol. 1982 Aug;49(2):419–425. [PubMed]
  • Monteiro RC, Halbwachs-Mecarelli L, Roque-Barreira MC, Noel LH, Berger J, Lesavre P. Charge and size of mesangial IgA in IgA nephropathy. Kidney Int. 1985 Oct;28(4):666–671. [PubMed]
  • Trascasa ML, Egido J, Sancho J, Hernando L. IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA. Clin Exp Immunol. 1980 Nov;42(2):247–254. [PubMed]
  • Clarkson AR, Seymour AE, Woodroffe AJ, McKenzie PE, Chan YL, Wootton AM. Controlled trial of phenytoin therapy in IgA nephropathy. Clin Nephrol. 1980 May;13(5):215–218. [PubMed]
  • Woodroffe AJ, Gormly AA, McKenzie PE, Wootton AM, Thompson AJ, Seymour AE, Clarkson AR. Immunologic studies in IgA nephropathy. Kidney Int. 1980 Sep;18(3):366–374. [PubMed]
  • Newkirk MM, Klein MH, Katz A, Fisher MM, Underdown BJ. Estimation of polymeric IgA in human serum: an assay based on binding of radiolabeled human secretory component with applications in the study of IgA nephropathy, IgA monoclonal gammopathy, and liver disease. J Immunol. 1983 Mar;130(3):1176–1181. [PubMed]
  • Feehally J, Beattie TJ, Brenchley PE, Coupes BM, Mallick NP, Postlethwaite RJ. Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int. 1986 Dec;30(6):924–931. [PubMed]
  • Doi T, Kanatsu K, Sekita K, Yoshida H, Nagai H, Hamashima Y. Detection of IgA class circulating immune complexes bound to anti-C3d antibody in patients with IgA nephropathy. J Immunol Methods. 1984 Apr 13;69(1):95–104. [PubMed]
  • Endoh M, Suga T, Miura M, Tomino Y, Nomoto Y, Sakai H. In vivo alteration of antibody production in patients with IgA nephropathy. Clin Exp Immunol. 1984 Sep;57(3):564–570. [PubMed]
  • Pasternack A, Mustonen J, Leinikki P. Humoral immune response in patients with IgA and IgM glomerulonephritis. Clin Exp Immunol. 1986 Jan;63(1):228–233. [PubMed]
  • Leinikki PO, Mustonen J, Pasternack A. Immune response to oral polio vaccine in patients with IgA glomerulonephritis. Clin Exp Immunol. 1987 Apr;68(1):33–38. [PubMed]
  • Brown TA, Murphy BR, Radl J, Haaijman JJ, Mestecky J. Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. J Clin Microbiol. 1985 Aug;22(2):259–264. [PMC free article] [PubMed]
  • Brown TA, Mestecky J. Immunoglobulin A subclass distribution of naturally occurring salivary antibodies to microbial antigens. Infect Immun. 1985 Aug;49(2):459–462. [PMC free article] [PubMed]
  • Mascart-Lemone FO, Duchateau JR, Oosterom J, Butzler JP, Delacroix DL. Kinetics of anti-Campylobacter jejuni monomeric and polymeric immunoglobulin A1 and A2 responses in serum during acute enteritis. J Clin Microbiol. 1987 Jul;25(7):1253–1257. [PMC free article] [PubMed]
  • Lue C, Tarkowski A, Mestecky J. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. J Immunol. 1988 Jun 1;140(11):3793–3800. [PubMed]
  • Kett K, Brandtzaeg P, Radl J, Haaijman JJ. Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J Immunol. 1986 May 15;136(10):3631–3635. [PubMed]
  • Tesch H, Müller W, Rajewsky K. Lymphokines regulate immunoglobulin isotype expression in an antigen-specific immune response. J Immunol. 1986 Apr 15;136(8):2892–2895. [PubMed]
  • Murray PD, McKenzie DT, Swain SL, Kagnoff MF. Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J Immunol. 1987 Oct 15;139(8):2669–2674. [PubMed]
  • Harriman GR, Strober W. Interleukin 5, a mucosal lymphokine? J Immunol. 1987 Dec 1;139(11):3553–3555. [PubMed]
  • Beagley KW, Eldridge JH, Kiyono H, Everson MP, Koopman WJ, Honjo T, McGhee JR. Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells. J Immunol. 1988 Sep 15;141(6):2035–2042. [PubMed]
  • van den Wall Bake AW, Daha MR, Haaijman JJ, Radl J, van der Ark A, van Es LA. Elevated production of polymeric and monomeric IgA1 by the bone marrow in IgA nephropathy. Kidney Int. 1989 Jun;35(6):1400–1404. [PubMed]
  • Negro Ponzi A, Merlino C, Angeretti A, Penna R. Virus-specific polymeric immunoglobulin A antibodies in serum from patients with rubella, measles, varicella, and herpes zoster virus infections. J Clin Microbiol. 1985 Oct;22(4):505–509. [PMC free article] [PubMed]
  • Mascart-Lemone F, Duchateau J, Conley ME, Delacroix DL. A polymeric IgA response in serum can be produced by parenteral immunization. Immunology. 1987 Aug;61(4):409–413. [PubMed]
  • Hiemstra PS, Baldwin WM, van der Voort EA, Paul LC, van Es LA, Daha MR. Polymeric IgA antibody response to rabbit antithymocyte globulin in renal transplant recipients. Transplantation. 1988 Apr;45(4):701–705. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation